Hoelscher Paul W. Insider Trades

Insider Trading History

Track insider trading activity for Hoelscher Paul W.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Sagimet Biosciences
Sagimet Biosciences SGMT
Director
Holding Value $279k 39,567 shares
Last Trade
Jun 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$256k 39,567 shares
$6.48
$7.06
Sagimet Biosciences
Sagimet Biosciences SGMT
Director
Holding Value $228k 32,250 shares
Last Trade
Jun 09, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$172k 32,250 shares
$5.33
$7.06
Sagimet Biosciences
Sagimet Biosciences SGMT
Director
Holding Value $65.5k 9,279 shares
Last Trade
Jun 05, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$43.1k 9,279 shares
$4.64
$7.06
Sagimet Biosciences
Sagimet Biosciences SGMT
Director
Holding Value $515k 73,014 shares
Last Trade
Apr 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$382k 73,014 shares
$5.23
$7.06
Reneo Pharmaceuticals
Reneo Pharmaceuticals RPHM
Director
Holding Value $319k 17,500 shares
Last Trade
Jun 06, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.58M 17,500 shares
$90.10
$18.20
Reneo Pharmaceuticals
Reneo Pharmaceuticals RPHM
Director
Holding Value $116k 6,376 shares
Last Trade
Jun 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$133k 6,376 shares
$20.90
$18.20
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
Evp, CFO
Holding Value $4.24M 36,424 shares
Last Trade
Apr 20, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.77M 50,000 shares
$115.43
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
Evp, CFO
Holding Value $122k 1,049 shares
Last Trade
Apr 20, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.48M 21,542 shares
$115.17
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
Evp, CFO
Holding Value $0 0 shares
Last Trade
Apr 06, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.3M 30,275 shares
$108.95
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
Evp, CFO
Holding Value $7.75M 66,673 shares
Last Trade
Apr 06, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$10.1M 91,710 shares
$110.01
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
Evp, CFO
Holding Value $8.47M 72,789 shares
Last Trade
Mar 23, 2022 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$18.7M 172,226 shares
$108.49
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
Evp, CFO
Holding Value $3.52M 30,275 shares
Last Trade
Mar 23, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.83M 26,090 shares
$108.49
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
Evp, CFO
Holding Value $18.7M 160,527 shares
Last Trade
Mar 23, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.29M 11,699 shares
$110.01
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
Evp, CFO
Holding Value $7.87M 67,675 shares
Last Trade
Jan 21, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$213k 2,463 shares
$86.42
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
Evp, CFO
Holding Value $8.16M 70,138 shares
Last Trade
Jan 21, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$480k 5,558 shares
$86.42
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
Evp, CFO
Holding Value $0 0 shares
Last Trade
Jan 21, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$480k 5,558 shares
$86.42
$116.30
Reneo Pharmaceuticals
Reneo Pharmaceuticals RPHM
Director
Holding Value $637k 35,000 shares
Last Trade
Jan 20, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.8M 35,000 shares
$80.10
$18.20
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
Evp, CFO
Holding Value $13.4M 115,246 shares
Last Trade
Jan 05, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.82M 47,375 shares
$101.84
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
Evp, CFO
Holding Value $2.71M 23,286 shares
Last Trade
Jan 05, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.81M 66,822 shares
$101.84
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
Evp, CFO
Holding Value $7.51M 64,580 shares
Last Trade
Jan 05, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$5.16M 50,666 shares
$101.84
$116.30

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up